Please provide your email address to receive an email when new articles are posted on . AI model lung function estimations agreed with spirometry. With the model, there were high area under the ...
Please provide your email address to receive an email when new articles are posted on . Three differing doses of ISM001-055 were assessed against placebo. Each was “well-tolerated.” Each group also ...
SAN DIEGO -- Two novel drugs improved lung function in idiopathic pulmonary fibrosis (IPF) in a pair of phase IIa trials, researchers reported here. In an open-label, single-arm trial of 46 patients ...
Nerandomilast significantly slowed lung function decline in patients with IPF, with the 18 mg dose showing a 68.8 mL FVC decline reduction compared with placebo. The trial included 1177 patients, 78% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results